A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

PHASE2CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

PH-797804

PH-797804 at four dose levels

DRUG

Placebo

Placebo

Trial Locations (45)

1125

Pfizer Investigational Site, Budapest

1900

Pfizer Investigational Site, La Plata

2000

Pfizer Investigational Site, Rosario

2050

Pfizer Investigational Site, Camperdown

4001

Pfizer Investigational Site, Durban

4126

Pfizer Investigational Site, Durban

5041

Pfizer Investigational Site, Daw Park

6009

Pfizer Investigational Site, Nedlands

6772

Pfizer Investigational Site, Deszk

7626

Pfizer Investigational Site, Pécs

9301

Pfizer Investigational Site, Bloemfontein

9700

Pfizer Investigational Site, Szombathely

10676

Pfizer Investigational Site, Athens

13009

Pfizer Investigational Site, Marseille

39001

Pfizer Investigational Site, Tábor

66000

Pfizer Investigational Site, Perpignan

150003

Pfizer Investigational Site, Yaroslavl

150023

Pfizer Investigational Site, Yaroslavl

2352499

Pfizer Investigational Site, Valparaíso

3460001

Pfizer Investigational Site, Talca

7500691

Pfizer Investigational Site, Providencia

C1425DQI

Pfizer Investigational Site, Buenos Aires

C1426ABP

Pfizer Investigational Site, Buenos Aires

C1428DDE

Pfizer Investigational Site, Ciudad Autonoma de Buenos Aires (caba)

V5Z 4E1

Pfizer Investigational Site, Vancouver

R2K 3S8

Pfizer Investigational Site, Winnipeg

L8N 3Z5

Pfizer Investigational Site, Hamilton

K7L 2V7

Pfizer Investigational Site, Kingston

G1V 4G5

Pfizer Investigational Site, Sainte-Foy

471 54

Pfizer Investigational Site, Cvikov

283 01

Pfizer Investigational Site, Kutná Hora

460 01

Pfizer Investigational Site, Liberec

153 00

Pfizer Investigational Site, Prague

387 01

Pfizer Investigational Site, Strakonice

59042 CEDEX

Pfizer Investigational Site, Lille

34295 CEDEX 5

Pfizer Investigational Site, Montpellier

711 10

Pfizer Investigational Site, Heraklion

41 110

Pfizer Investigational Site, Larissa

H-1036

Pfizer Investigational Site, Budapest

1311 RL

Pfizer Investigational Site, Almere Stad

7207 BA

Pfizer Investigational Site, Zutphen

431-070

Pfizer Investigational Site, Anyang

135-710

Pfizer Investigational Site, Seoul

138-736

Pfizer Investigational Site, Seoul

EH16 4SA

Pfizer Investigational Site, Edinburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY